A nucleotide-based drug protects against glutamate- and MPP+ -induced neurotoxicity
Nucleo CMP Forte® is a nucleotide-based drug consisting of cytidinemonophosphate, uridinemonophosphate, uridin-ediphosphate and uridinetriphosphate. It has been prescribed for peripheral nervous system disorders, such as lum-bosciatalgia, diabetic or alcoholic polyneuropathy, or trigeminal neuralgia. Its effects on brain pathologies has re-ceived little attention. We examined its neuroprotective effects on cell toxicity induced by glutamate excitotoxicity or by 1-methyl-4-phenyl-pyridinium (MPP+), an in vitro cell model of Parkinson’s disease. We used the human dopaminergic cell line SH-SY5Y and a primary culture of rat cortical cells pre-treated with the drug for 24 hours and then exposed to MPP+ or glutamate at a range of concentrations. Cell viability was measured at different times. Nucleo CMP Forte® pre-treatment significantly increased the rate of cell division in SH-SY5Y cells, as well as the synthesis of triglycerides and phospholipids. More interestingly, drug pre-treatment significantly reduced MPP+- and glutamate-induced cell death in SH-SY5Y cells and in rat cortical cells. These results indicate that the nucleotides included in Nucleo CMP Forte® are promising therapeutic molecules for the prevention of neuronal death in brain caused by focal ischemia, Parkinson’s disease or other neurodegenerative pathologies.
61 - Medicina
Parkinson, Malaltia de
Parkinson, Enfermedad de
Is part of
Neuroscience & Medicine
Gella, Alejandro; Martiañez, Tania; Lamarca, Aloa [et al.]. A nucleotide-based drug protects against glutamate- and MPP+ -induced neurotoxicity. Neuroscience & Medicine, 2011, vol. 2, p. 154-160. Disponible en: <https://www.scirp.org/journal/paperinformation.aspx?paperid=5538>. Fecha de acceso: 22 feb. 2020. DOI: 10.4236/nm.2011.22022
Grant agreement number
This item appears in the following Collection(s)
© 2020 by authors and Scientific Research Publishing Inc. This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.
The following license files are associated with this item:
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0/